Clinical Trials Browser

Active not recruiting × sintilimab × Thoracic × Clear all

NCT07005336 2026-01-30

A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT05116462 2025-06-26

Neoadjuvant and Adjuvant Therapy Studies of Sindilizumab in Resectable Lung Cancer

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT05400070 2024-10-18

Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC

Phase 2 Active not recruiting

Lung Neoplasms

NCT05244213 2024-07-08

NEOTIDE

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT04326153 2024-02-01

Neo-Pre-IC

Phase 2 Active not recruiting

IIIA Stage Non-small Cell Lung Cancer